These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 18560226)

  • 21. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
    Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
    Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
    Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
    Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells.
    Chan KF; Zhao Y; Burkett BA; Wong IL; Chow LM; Chan TH
    J Med Chem; 2006 Nov; 49(23):6742-59. PubMed ID: 17154505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of curcumin mimics with multidrug resistance reversal activities.
    Um Y; Cho S; Woo HB; Kim YK; Kim H; Ham J; Kim SN; Ahn CM; Lee S
    Bioorg Med Chem; 2008 Apr; 16(7):3608-15. PubMed ID: 18295490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 20(S)-Protopanaxadiol (PPD) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs.
    Liu J; Wang X; Liu P; Deng R; Lei M; Chen W; Hu L
    Bioorg Med Chem; 2013 Jul; 21(14):4279-87. PubMed ID: 23683834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance.
    Chanmahasathien W; Ampasavate C; Greger H; Limtrakul P
    Phytomedicine; 2011 Jan; 18(2-3):199-204. PubMed ID: 20739156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
    Zou ZH; Lan XB; Qian H; Huang WL; Li YM
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901.
    Wang J; Xia Y; Wang H; Hou Z
    Integr Cancer Ther; 2007 Dec; 6(4):400-4. PubMed ID: 18048888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug resistant breast cancer cells overexpress ETS1 gene.
    Kars MD; Işeri OD; Gündüz U
    Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.
    Xu HB; Li L; Fu J; Mao XP; Xu LZ
    Pharmacology; 2012; 89(5-6):303-12. PubMed ID: 22573000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
    Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel multidrug resistance reversal agents.
    Berger D; Citarella R; Dutia M; Greenberger L; Hallett W; Paul R; Powell D
    J Med Chem; 1999 Jun; 42(12):2145-61. PubMed ID: 10377220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers.
    Tatosian DA; Shuler ML
    Biotechnol Bioeng; 2009 May; 103(1):187-98. PubMed ID: 19137589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
    Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
    Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
    Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
    Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil.
    Zhang L; Yang Y; Wei XY; Shi YR; Liu HY; Niu RF; Hao XS
    J Exp Clin Cancer Res; 2007 Jun; 26(2):201-7. PubMed ID: 17725099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic effects and in vitro reversal of multidrug resistance by therapeutic ultrasound in human hepatocarcinoma cell line (HepG2).
    Shao ZY; Zhai BJ; Zhao CL; Hu K; Shen DM; Wu F
    Ultrasonics; 2008 Aug; 48(4):297-302. PubMed ID: 18199465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.